Olumiant (Baricitinib)

Olumiant contains baricitinib, which is taken by adults to treat moderate to severe active rheumatoid arthritis who have inadequate response or intolerance to other anti-rheumatic medicines.  Olumiant reduces the enzymatic activity of Janus kinase which is involved in the inflammatory process.  Olumiant works in the body to reduce stiffness, swelling, pain, and tiredness.  Olumiant also slows the damage to bone cartilage in the joints.

Olumiant is usually taken at a daily dose of 4mg.  Some patients will be taking the lower dose 2mg per day. Olumiant is used alone or along with methotrexate under the direction of a doctor which specializes in rheumatoid arthritis.